Search

everythinglearnresearchcommunity

for

Search:↓

Melanoma research shifted focus to immunotherapy drugs after 2010, increasing their study and citations.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

αMSH may help regulate immune responses in hair follicles and its disruption could lead to hair loss.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.

Overexpressing Merkel cell virus proteins in human hair follicles can create clusters of cells that resemble Merkel cell cancer.

Mesenchymal stem cells may help reduce melanin in UV-exposed mice.

A new mouse model effectively mimics vitiligo for research and drug testing.

Melanocytes are cells that make skin and hair color and help protect skin from sun damage.

TPA is about 50 times more effective at promoting tumors than MZ.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Patients with melanoma who saw dermatologists and were from higher-income areas were more likely to have follow-up visits, which was linked to lower mortality.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Exosomal miR-199a-3p from dermal papilla cells helps control hair color by affecting melanocytes.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Exosomal miR-222-3p reduces melanin production in rabbits by targeting the SOX10 gene.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Some skin growths with mucin can form hair follicles and resemble skin cancer, but a special stain can help tell them apart.

Different types of stem cells in the skin contribute to the variety of melanoma forms.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.